Theranostic Targeting of GRPR and PSMA in Prostate Cancer

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Search: onr:"swepub:oai:DiVA.org:uu-501391" > Theranostic Targeti...

1 of 1
Previous record
Next record
To hitlist

Theranostic Targeting of GRPR and PSMA in Prostate Cancer

Abouzayed, Ayman, 1992- (author): Uppsala universitet,Institutionen för läkemedelskemi,Theranostics

Orlova, Anna, Professor, 1960- (thesis advisor): Uppsala universitet,Institutionen för läkemedelskemi

Rosenström, Ulrika, Senior Lecturer (thesis advisor): Uppsala universitet,Institutionen för läkemedelskemi

Vorobyeva, Anzhelika, Associate Professor (thesis advisor): Uppsala universitet,Institutionen för immunologi, genetik och patologi

Mitran, Bogdan, Researcher (thesis advisor): Uppsala universitet,Translationell avbildning med PET,Antaros Medical AB

Müller, Cristina, PD Dr. (opponent): Center for Radiopharmaceutical Sciences, the Paul Scherrer Institute

show less...

(creator_code:org_t)

ISBN 9789151318288
Uppsala : Acta Universitatis Upsaliensis, 2023
English 94 s.
Series: Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, 1651-6192 ; 335

Related links:: https://uu.diva-port... (primary) (Raw object); show more...; https://uu.diva-port... (Preview); https://urn.kb.se/re...; show less...

Doctoral thesis (other academic/artistic)

Abstract Subject headings

This thesis is based on five original articles that investigated the theranostics of prostate cancer by gastrin-releasing peptide receptor (GRPR) and prostate-specific membrane antigen (PSMA) targeting. GRPR and PSMA are two extensively evaluated prostate cancer cell markers due to their overexpression in the majority of prostate cancer samples. Theranostic targeting of GRPR and PSMA is an attractive strategy to improve the management of prostate cancer patients.Papers I and II focused on the dual targeting of GRPR and PSMA. The effect of linker modification on the affinity for GRPR and PSMA and the pharmacokinetic profile was evaluated. In Paper III, the effect of the GRPR antagonist RM26 conjugation to an albumin-binding domain on the pharmacokinetic profile and its potential use in therapy was investigated. Paper IV focused on developing a GRPR antagonist that was suitable for single-photon emission computed tomography (SPECT) using technetium-99m. In Paper V, the GRPR antagonist developed in Paper IV was translated into a phase I clinical trial to assess safety and dosimetry.Modifying the linkers in GRPR and PSMA heterodimers can largely impact the affinity for both targets. This modification influenced the in vivo targeting specificity and biodistribution, with [125I]I-BO530 in Paper I and [111In]In-BQ7812 in Paper II outperforming other analogues. Our findings in Paper III indicated that the conjugation of an albumin-binding domain to RM26 increased the blood concentration of the radiotracer. This increase led to elevated and stable tumour uptake of [111In]In-DOTA-ABD-RM26 after several days of injection. However, [111In]In-DOTA-ABD-RM26 was also increasingly taken up by various healthy organs. The GRPR antagonist [99mTc]Tc-maSSS-PEG2-RM26, studied in Paper IV, showed high specificity and affinity for GRPR. This resulted in elevated GRPR-mediated uptake. Additionally, maSSS-PEG2-RM26 could be radiolabelled via a straightforward radiolabelling protocol. Clinical evaluation of [99mTc]Tc-maSSS-PEG2-RM26 in prostate and breast cancer patients (Paper V) demonstrated the safety and tolerability of the radiotracer, with favourable dosimetry and no side effects.In conclusion, this thesis evaluated different tools for the theranostic targeting of GRPR and PSMA. The findings warrant further investigation to optimise the reported radiotracers.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Läkemedelskemi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Medicinal Chemistry (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

prostate cancer
gastrin-releasing peptide receptor (GRPR)
prostate-specific membrane antigen (PSMA)
nuclear medicine
molecular imaging
radiotracers
theranostics
Farmaceutisk vetenskap
Pharmaceutical Science
Oncology
Onkologi

Publication and Content Type

vet (subject category)
dok (subject category)

Find in a library

Theranostic Targeting of GRPR and PSMA in Prostate Cancer (Search the publication in LIBRIS)

To the university's database

1 of 1
Previous record
Next record
To hitlist

Find more in SwePub

By the author/editor: Abouzayed, Ayman ...; Orlova, Anna, Pr ...; Rosenström, Ulri ...; Vorobyeva, Anzhe ...; Mitran, Bogdan, ...; Müller, Cristina ...

About the subject

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Basic Medicine; and Medicinal Chemis ...

MEDICAL AND HEALTH SCIENCES: MEDICAL AND HEAL ...; and Clinical Medicin ...; and Cancer and Oncol ...

Parts in the series: Digital Comprehe ...

By the university: Uppsala University

Search outside SwePub

Extend your search to:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se